Diagnosis of extrapulmonary tuberculosis by GeneXpert MTB/RIF Ultra assay

References

• Global tuberculosis report 2022. Geneva: World Health Organization; 2022.
   Google Scholar
• Katale BZ, Mbelele PM, Lema NA, et al. Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania. BMC Genomics. 2020;21(1):1–5. doi: 10.1186/s12864-020-6577-1
   Web of Science ®Google Scholar
• Prasad R, Gupta N, Banka A. Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: principles of management. Lung India. 2018;35(1):78–81. doi: 10.4103/lungindia.lungindia_98_17
   PubMed Web of Science ®Google Scholar
• Mehta PK, Raj A, Singh N, et al. Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol Med Microbiol. 2012;66(1):20–36. doi: 10.1111/j.1574-695X.2012.00987.x
   PubMedGoogle Scholar
• Rindi L. Rapid molecular diagnosis of extra-pulmonary tuberculosis by Xpert/RIF Ultra. Front Microbiol. 2022;13:817661.
   PubMed Web of Science ®Google Scholar
• Antel K, Oosthuizen J, Malherbe F, et al. Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis. BMC Infect Dis. 2020;20(1):1–8. doi: 10.1186/s12879-019-4749-x
   Web of Science ®Google Scholar
• Mor P, Dahiya B, Parshad S, et al. Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests. Expert Rev Gastroenterol Hepatol. 2022;16(1):33–49. doi: 10.1080/17474124.2022.2021068
   PubMed Web of Science ®Google Scholar
• Kumari R, Tripathi R, Pandey AP, et al. Rapid screening of MDR-TB in cases of extra pulmonary tuberculosis using geno type MTBDR plus. PLoS One. 2016;11(7):e0159651. doi: 10.1371/journal.pone.0159651
   PubMed Web of Science ®Google Scholar
• Sharma SK, Chaubey J, Singh BK, et al. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India. Int J Tuberc Lung Dis. 2017;21(10):1112–1117. doi: 10.5588/ijtld.16.0939
   PubMed Web of Science ®Google Scholar
• Kamra E, Sharma S, Sheoran A, et al. Identification of mycobacterial MPT-64 and ESAT-6 proteins in urogenital tuberculosis patients by real-time immuno-PCR. Future Microbiol. 2022;17:829–842. doi: 10.2217/fmb-2022-0037
   PubMed Web of Science ®Google Scholar
• Mor P, Sheoran A, Dahiya B, et al. Diagnosis of abdominal tuberculosis by multi‐targeted (mpt64 and IS6110) loop‐mediated isothermal amplification assay. J Gastroenterol Hepatol. 2022;37(12):2264–2271. doi: 10.1111/jgh.16036
   PubMed Web of Science ®Google Scholar
• Shinnick TM, Starks AM, Alexander HL, et al. Evaluation of the Cepheid Xpert MTB/RIF assay. Expert Rev Mol Diagn. 2015;15(1):9–22. doi: 10.1586/14737159.2015.976556
   PubMed Web of Science ®Google Scholar
• Dahiya B, Kamra E, Alam D, et al. Insight into diagnosis of female genital tuberculosis. Expert Rev Mol Diagn. 2022;22(6):625–642. doi: 10.1080/14737159.2022.2016395
   PubMed Web of Science ®Google Scholar
• Soni A, Guliani A, Nehra K, et al. Insight into diagnosis of pleural tuberculosis with special focus on nucleic acid amplification tests. Expert Rev Respir Med. 2022;16(8):887–906. doi: 10.1080/17476348.2022.2093189
   PubMed Web of Science ®Google Scholar
• Wu X, Tan G, Gao R, et al. Assessment of the Xpert MTB/RIF Ultra assay on rapid diagnosis of extrapulmonary tuberculosis. Int J Infect Dis. 2019;81:91–96. doi: 10.1016/j.ijid.2019.01.050
   PubMed Web of Science ®Google Scholar
• Mahomed S, Mlisana K, Cele L, et al. Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: impact on bedside clinical decision making. J Clin Tuberc Other Mycobact Dis. 2020;20:100176. doi: 10.1016/j.jctube.2020.100176
   PubMedGoogle Scholar
• Opota O, Mazza-Stalder J, Greub G, et al. The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect. 2019;25(11):1370–1376. doi: 10.1016/j.cmi.2019.03.021
   PubMed Web of Science ®Google Scholar
• Donovan J, Cresswell FV, Thuong NT, et al. Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: a small step forward. Clin Infect Dis. 2020;71(8):2002–2005. doi: 10.1093/cid/ciaa473
   PubMed Web of Science ®Google Scholar
• Goig GA, Cancino-Muñoz I, Torres-Puente M, et al. Whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational study. Lancet Microbe. 2020;1(4):e175–83. doi: 10.1016/S2666-5247(20)30060-4
   PubMedGoogle Scholar
• MacLean E, Kohli M, Weber SF, et al. Advances in molecular diagnosis of tuberculosis. J Clin Microbiol. 2020;58(10):e01582–19. doi: 10.1128/JCM.01582-19
   PubMed Web of Science ®Google Scholar
• Park M, Kon OM. Use of Xpert MTB/RIF and Xpert Ultra in extrapulmonary tuberculosis. Expert Rev Anti Infect Ther. 2021;19(1):65–77. doi: 10.1080/14787210.2020.1810565
   PubMed Web of Science ®Google Scholar
• Kohli M, Schiller I, Dendukuri N, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1(1): CD012768. doi: 10.1002/14651858.CD012768.pub3
   PubMedGoogle Scholar
• Ministry of Health and Family Welfare, Government of India and World Health Organization. INDEX TB guidelines: guidelines on extra-pulmonary tuberculosis for India. New Delhi: MoHFW; 2016.
   Google Scholar
• Chawla K, Gupta S, Mukhopadhyay C, et al. PCR for M. tuberculosis in tissue samples. J Infect Dev Ctries. 2009;3(2):83–87. doi: 10.3855/jidc.53
   PubMed Web of Science ®Google Scholar
• Chakravorty S, Sen MK, Tyagi JS. Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology. J Clin Microbiol. 2005;43(9):4357–4362. doi: 10.1128/JCM.43.9.4357-4362.2005
   PubMed Web of Science ®Google Scholar
• Makeshkumar V, Madhavan R, Narayanan S. Polymerase chain reaction targeting insertion sequence for the diagnosis of extrapulmonary tuberculosis. Indian J Med Res. 2014;139(1):161.
   PubMedGoogle Scholar
• Zamirian M, Mokhtarian M, Motazedian MH, et al. Constrictive pericarditis: detection of Mycobacterium tuberculosis in paraffin-embedded pericardial tissues by polymerase chain reaction. Clin Biochem. 2007;40(5–6):355–358. doi: 10.1016/j.clinbiochem.2006.12.005
   PubMed Web of Science ®Google Scholar
• Araya S, Negesso AE, Tamir Z. Rifampicin-resistant Mycobacterium tuberculosis among patients with presumptive tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2020:3451–3459. doi: 10.2147/IDR.S263023
   Google Scholar
• Ngabonziza JC, Decroo T, Migambi P, et al. Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda. Lancet Microbe. 2020;1(2):e74–83. doi: 10.1016/S2666-5247(20)30007-0
   PubMedGoogle Scholar
• Rufai SB, Kumar P, Singh A, et al. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis. J Clin Microbiol. 2014;52(6):1846–1852. doi: 10.1128/JCM.03005-13
   PubMed Web of Science ®Google Scholar
• Chakravorty S, Kothari H, Aladegbami B, et al. Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding. J Clin Microbiol. 2012;50(7):2194–2202. doi: 10.1128/JCM.00143-12
   PubMed Web of Science ®Google Scholar
• Eddabra R, Ait Benhassou H. Rapid molecular assays for detection of tuberculosis. Pneumonia. 2018;10(1):4. doi: 10.1186/s41479-018-0049-2
   Google Scholar
• World Health Organisation. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: xpert MTB/RIF system. Policy Statement Geneva, World Health Org. 2011. https://apps.who.int/iris/handle/10665/44586
   Google Scholar
• World Health Organisation. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. 2013. https://apps.who.int/iris/handle/10665/112472.
   Google Scholar
• Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6(9):1067–1082. doi: 10.2217/fmb.11.84
   PubMed Web of Science ®Google Scholar
• Gaude GS, Vishwanath S. Molecular diagnosis of tuberculosis with emphasis on Xpert Mycobacterium tuberculosis assay–Clinical review. J Clin Sci. 2020;17(4):93. doi: 10.4103/jcls.jcls_52_19
   Google Scholar
• Alemu A, Tadesse M, Seid G, et al. Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia. BMC Infect Dis. 2020;20(1):87. doi: 10.1186/s12879-020-4817-2
   PubMed Web of Science ®Google Scholar
• Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010;48(7):2495–2501. doi: 10.1128/JCM.00128-10
   PubMed Web of Science ®Google Scholar
• Chakravorty S, AM S, Rowneki M, et al. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio 2017;8(4):p. e00812–17.
   PubMed Web of Science ®Google Scholar
• Williamson DA, Basu I, Bower J, et al. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis. 2012;74(2):207–209. doi: 10.1016/j.diagmicrobio.2012.06.013
   PubMed Web of Science ®Google Scholar
• Cepheid. Xpert MTB/RIF Ultra Product Brochure. 2017.
   Google Scholar
• van Zyl-Smit RN, Binder A, Meldau R, et al. Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden. PLoS One. 2011;6(12):e28815. doi: 10.1371/journal.pone.0028815
   PubMed Web of Science ®Google Scholar
• Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76–84. doi: 10.1016/S1473-3099(17)30691-6
   PubMed Web of Science ®Google Scholar
• Minnies S, Reeve BW, Rockman L, et al. Xpert MTB/RIF Ultra is highly sensitive for the diagnosis of tuberculosis lymphadenitis in a high-HIV setting. J Clin Microbiol. 2021;59(12):e0131621. doi: 10.1128/JCM.01316-21
   PubMed Web of Science ®Google Scholar
• Gao S, Wang C, Yu X, et al. Xpert MTB/RIF Ultra enhanced tuberculous pleurisy diagnosis for patients with unexplained exudative pleural effusion who underwent a pleural biopsy via thoracoscopy: a prospective cohort study. Int J Infect Dis. 2021;106:370–375. doi: 10.1016/j.ijid.2021.04.011
   PubMed Web of Science ®Google Scholar
• Sun Q, Wang S, Dong W, et al. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis. J Infect. 2019;79(2):153–158. doi: 10.1016/j.jinf.2019.06.006
   PubMed Web of Science ®Google Scholar
• Wang G, Wang S, Yang X, et al. Accuracy of Xpert MTB/RIF Ultra for the diagnosis of pleural TB in a multicenter cohort study. Chest. 2020;157(2):268–275. doi: 10.1016/j.chest.2019.07.027
   PubMed Web of Science ®Google Scholar
• Piersimoni C, Gherardi G, Gracciotti N, et al. Comparative evaluation of Xpert MTB/RIF and the new Xpert MTB/RIF ultra with respiratory and extra-pulmonary specimens for tuberculosis case detection in a low incidence setting. J Clin Tuberc Other Mycobact Dis. 2019;15:100094. doi: 10.1016/j.jctube.2019.100094
   PubMedGoogle Scholar
• Amedeo A, Beci G, Giglia M, et al. Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings. PLoS One. 2022;17(8):e0272997. doi: 10.1371/journal.pone.0272997
   PubMed Web of Science ®Google Scholar
• World Health Organisation WHO. Meeting report of a technical expert-consultation: non-inferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF. Geneva: 2017. https://www.who.int/publications/i/item/WHO-HTM-TB-2017.04
   Google Scholar
• World Health Organization. WHO guidelines approved by the guidelines review committee WHO consolidated guidelines on tuberculosis: module 3: diagnosis-rapid diagnostics for tuberculosis detection. Geneva. 2020 https://www.who.int/publications/i/item/9789240029415.
   Google Scholar
• Chilukutu L, Mwanza W, Kerkhoff AD, et al. Prevalence and interpretation of Xpert® Ultra trace results among presumptive TB patients. Public Health Action. 2022;12(1):28–33. doi: 10.5588/pha.21.0066
   PubMed Web of Science ®Google Scholar
• Fantahun M, Kebede A, Yenew B, et al. Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis. PLoS One. 2019;14(9):e0222402. doi: 10.1371/journal.pone.0222402
   PubMed Web of Science ®Google Scholar
• Fernandez-Pittol M, Zboromyrska Y, Román A, et al. Retrospective diagnosis of lymphatic tuberculosis in frozen samples using two genetic amplification methods, Xpert® MTB/RIF ULTRA and Abbott RealTime MTB Assay. Rev Esp Quimioter. 2021;34(6):660–663. doi: 10.37201/req/074.2021
   PubMed Web of Science ®Google Scholar
• Romdhane E, Arfaoui A, Benabdessalem C, et al. Performance of GeneXpert ultra in the diagnosis of Tuberculous Cervical lymphadenitis in formalin fixed paraffin embedded tissues. Tuberculosis (Edinb). 2020;125:102012. doi: 10.1016/j.tube.2020.102012
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang T, Kong Y, et al. Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study. Int J Infect Dis. 2022;122:741–746. doi: 10.1016/j.ijid.2022.07.039
   PubMed Web of Science ®Google Scholar
• Cresswell FV, Tugume L, Bahr NC, et al. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. Lancet Infect Dis. 2020;20(3):308–317. doi: 10.1016/S1473-3099(19)30550-X
   PubMed Web of Science ®Google Scholar
• López-Roa P, Martin-Higuera C, Ruiz-Serrano MJ, et al. Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence Diagn Microbiol Infect Dis. Diagn Microbiol Infect Dis. 2021;99(2):115235. doi: 10.1016/j.diagmicrobio.2020.115235
   PubMed Web of Science ®Google Scholar
• Mekkaoui L, Hallin M, Mouchet F, et al. Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium. PLoS One. 2021;16(4):e0249734. doi: 10.1371/journal.pone.0249734
   PubMed Web of Science ®Google Scholar
• Peñata-Bedoya A, Zuluaga-Avendaño S, Castaño-Sepúlveda T, et al. Performance of real-time semi-quantitative polymerase chain reaction assay for optimum diagnosis of extrapulmonary tuberculosis and sensitivity to rifampin in a tertiary care center. Rev Invest Clin. 2021;73(6):354–361. doi: 10.24875/RIC.21000040
   PubMedGoogle Scholar
• Perez-Risco D, Rodriguez-Temporal D, Valledor-Sanchez I, et al. Evaluation of the Xpert MTB/RIF Ultra assay for direct detection of Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples. J Clin Microbiol. 2018;56(9):e00659–18. doi: 10.1128/JCM.00659-18
   PubMed Web of Science ®Google Scholar
• Kaswala C, Schmiedel Y, Kundu D, et al. Accuracy of Xpert MTB/RIF Ultra for the diagnosis of tuberculosis in adult patients: a retrospective cohort study. Int J Infect Dis. 2022;122:566–568. doi: 10.1016/j.ijid.2022.07.016
   PubMed Web of Science ®Google Scholar
• Hoel IM, Syre H, Skarstein I, et al. Xpert MTB/RIF ultra for rapid diagnosis of extrapulmonary tuberculosis in a high-income low-tuberculosis prevalence setting. Sci Rep. 2020;10(1):13959. doi: 10.1038/s41598-020-70613-x
   PubMed Web of Science ®Google Scholar
• Shaw JA, Diacon AH, Koegelenberg CF. Tuberculous pleural effusion. Respirology. 2019;24(10):962–971. doi: 10.1111/resp.13673
   PubMed Web of Science ®Google Scholar
• Meldau R, Randall P, Pooran A, et al. Same-day tools, including Xpert Ultra and IRISA-TB, for rapid diagnosis of pleural tuberculosis: a prospective observational study. J Clin Microbiol. 2019;57(9):e00614–19. doi: 10.1128/JCM.00614-19
   PubMed Web of Science ®Google Scholar
• Gao Y, Ou Q, Huang F, et al. Improved diagnostic power by combined interferon-gamma release assay and nested-PCR in tuberculous pleurisy in high tuberculosis prevalence area. FEMS Microbiol Immunol. 2012;66:393–398. doi: 10.1111/1574-695X.12006
   Google Scholar
• Christopher DJ, Dinakaran S, Gupta R, et al. Thoracoscopic pleural biopsy improves yield of Xpert MTB/RIF for diagnosis of pleural tuberculosis. Respirology. 2018;23(7):714–717. doi: 10.1111/resp.13275
   PubMed Web of Science ®Google Scholar
• Wang G, Wang S, Jiang G, et al. Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study. J Infect. 2019;78(4):311–316. doi: 10.1016/j.jinf.2019.02.010
   PubMed Web of Science ®Google Scholar
• Aggarwal AN, Agarwal R, Dhooria S, et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: a systematic review and comparative meta-analysis. PLoS One. 2022;17(7):e0268483. doi: 10.1371/journal.pone.0268483
   PubMedGoogle Scholar
• Yu W, Shen Y, Zhu P, et al. Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: a systematic review and meta-analysis. Medicine (Baltimore). 2022;101(20):e29363. doi: 10.1097/MD.0000000000029363
   PubMed Web of Science ®Google Scholar
• Sharma K, Sharma M, Shree R, et al. Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: a diagnostic accuracy study from India. Tuberculosis (Edinb). 2020;125:101990. doi: 10.1016/j.tube.2020.101990
   PubMed Web of Science ®Google Scholar
• Chin JH, Ssengooba W, Grossman S, et al. Xpert MTB/RIF Ultra: optimal procedures for the detection of Mycobacterium tuberculosis in cerebrospinal fluid. J Clin Tuberc Other Mycobact Dis. 2019;14:16–18. doi: 10.1016/j.jctube.2019.01.002
   PubMedGoogle Scholar
• Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis. 2018;18(1):68–75. doi: 10.1016/S1473-3099(17)30474-7
   PubMed Web of Science ®Google Scholar
• Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803–812. doi: 10.1016/S1473-3099(10)70138-9
   PubMed Web of Science ®Google Scholar
• Donovan J, Phu NH, Dung VT, et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect Dis. 2020;20(3):299–307. doi: 10.1016/S1473-3099(19)30649-8
   PubMed Web of Science ®Google Scholar
• Huang M, Wang G, Sun Q, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China. Diagn Microbiol Infect Dis. 2021;100(1):115306. doi: 10.1016/j.diagmicrobio.2020.115306
   PubMed Web of Science ®Google Scholar
• Martyn EM, Bangdiwala AS, Kagimu E, et al. Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra polymerase chain reaction cycle threshold value predicts 2-week mortality in human immunodeficiency virus–associated tuberculous meningitis. Clin Infect Dis. 2021;73(9):e3505–e3510. doi: 10.1093/cid/ciaa1444
   PubMed Web of Science ®Google Scholar
• Yadav B, Sharma M, Singla N, et al. Molecular diagnosis of Tuberculous meningitis: sdaA-based multi-targeted LAMP and GeneXpert Ultra. Tuberculosis. 2023;140:102339. doi: 10.1016/j.tube.2023.102339
   PubMed Web of Science ®Google Scholar
• Shao L, Qiu C, Zheng L, et al. Comparison of diagnostic accuracy of the GeneXpert Ultra and cell-free nucleic acid assay for tuberculous meningitis: a multicentre prospective study. Int J Infect Dis. 2020;98:441–446. doi: 10.1016/j.ijid.2020.06.076
   PubMed Web of Science ®Google Scholar
• Sharma K, Sharma M, Batra N, et al. Diagnostic potential of multi‐targeted LAMP (loop‐mediated isothermal amplification) for osteoarticular tuberculosis. J Orthop Res. 2017;35(2):361–365. doi: 10.1002/jor.23293
   PubMed Web of Science ®Google Scholar
• Khan A, Kamra E, Singh R, et al. Diagnosis of osteoarticular tuberculosis: multi-targeted loop-mediated isothermal amplification assay versus multiplex PCR. Future Microbiol. 2021;16:935–948. doi: 10.2217/fmb-2021-0030
   PubMed Web of Science ®Google Scholar
• Romdhane E, Rammeh S, Bouaziz CM, et al. Performances of single tube nested polymerase chain reaction and GeneXpert ultra on Formalin fixed paraffin embedded tissues in the diagnosis of tuberculous spondylodiscitis. Clin Rheumatol. 2021;40(10):4317–4323. doi: 10.1007/s10067-021-05782-9
   PubMed Web of Science ®Google Scholar
• Figueiredo AA, Lucon AM, Srougi M, et al. Urogenital tuberculosis. Microbiol Spectr. 2017;5(1). doi: 10.1128/microbiolspec.TNMI7-0015-2016
   PubMed Web of Science ®Google Scholar
• Kamra E, Mehta PK. Current updates in diagnosis of male urogenital tuberculosis. Expert Rev Anti Infect Ther. 2021;19(10):1175–1190. doi: 10.1080/14787210.2021.1902305
   PubMed Web of Science ®Google Scholar
• Atherton RR, Cresswell FV, Ellis J, et al. Detection of Mycobacterium tuberculosis in urine by Xpert MTB/RIF Ultra: a useful adjunctive diagnostic tool in HIV-associated tuberculosis. Int J Infect Dis. 2018;75:92–94. doi: 10.1016/j.ijid.2018.07.007
   PubMed Web of Science ®Google Scholar
• Pradeep I, Anupama S, Koshy P, et al. A rare association of Mycobacterium tuberculosis infection of kidney and urinary tract with immunoglobulin a nephropathy. Indian J Med Microbiol. 2019;37(4):587–589. doi: 10.4103/ijmm.IJMM_19_482
   PubMed Web of Science ®Google Scholar
• Basu S, Monira S, Modi RR, et al. Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4(1):3. doi: 10.1186/1869-5760-4-3
   PubMedGoogle Scholar
• Sharma K, Sharma M, Ayyadurai N, et al. Comparative Evaluation of GeneXpert MTB/RIF Ultra and GeneXpert MTB/RIF for detecting tuberculosis and identifying Rifampicin resistance in pars plana vitrectomy samples of patients with ocular tuberculosis. Ocul Immunol Inflamm. 2022;2022:1–7. doi: 10.1080/09273948.2022.2064880
   Google Scholar
• Muneer A, Macrae B, Krishnamoorthy S, et al. Urogenital tuberculosis-epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019;16:573–598. doi: 10.1038/s41585-019-0228-9
   PubMed Web of Science ®Google Scholar
• World Health Organization. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update (2019): evidence to decision tables. WHO. 2019. https://apps.who.int/iris/bitstream/handle/10665/329479/9789241550604-eng.pdf?sequence=1&isAllowed=y
   Google Scholar
• Lawn SD, Gupta-Wright A. Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications. Trans R Soc Trop Med Hyg. 2016;110(3):180–185. doi: 10.1093/trstmh/trw008
   PubMed Web of Science ®Google Scholar
• Wood R, Racow K, Bekker LG, et al. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infect Dis. 2012;12(1):47. doi: 10.1186/1471-2334-12-47
   PubMedGoogle Scholar
• Gupta-Wright A, Corbett EL, van Oosterhout JJ, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet. 2018;392(10144):292–301. doi: 10.1016/S0140-6736(18)31267-4
   PubMed Web of Science ®Google Scholar
• Boloko L, Schutz C, Sibiya N, et al. Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort study. Lancet Microbe. 2022;3(7):e521–32. doi: 10.1016/S2666-5247(22)00062-3
   PubMedGoogle Scholar
• Shen Y, Yu G, Zhao W, et al. Efficacy of Xpert MTB/RIF Ultra in diagnosing tuberculosis meningitis: a systematic review and meta-analysis. Medicine (Baltimore). 2021;100(29):e26778. doi: 10.1097/MD.0000000000026778
   PubMed Web of Science ®Google Scholar
• Dahiya B, Khan A, Mor P, et al. Detection of Mycobacterium tuberculosis lipoarabinomannan and CFP-10 (Rv3874) from urinary extracellular vesicles of tuberculosis patients by immuno-PCR. Pathog Dis. 2019;77(5):ftz049. doi: 10.1093/femspd/ftz049
   PubMed Web of Science ®Google Scholar
• Kamra E, Singh N, Khan A, et al. Diagnosis of genitourinary tuberculosis by loop-mediated isothermal amplification based on SYBR Green I dye reaction. Biotechniques. 2022;73(1):47–57. doi: 10.2144/btn-2022-0027
   PubMed Web of Science ®Google Scholar
• Cao Y, Parmar H, Gaur RL, et al. Xpert MTB/XDR: a 10-color reflex assay suitable for point-of-care settings to detect isoniazid, fluoroquinolone, and second-line-injectable-drug resistance directly from Mycobacterium tuberculosis-positive sputum. J Clin Microbiol. 2021;59(3):e02314–20. doi: 10.1128/JCM.02314-20
   PubMed Web of Science ®Google Scholar
• Bainomugisa A, Gilpin C, Coulter C, et al. New Xpert MTB/XDR: added value and future in the field. Eur Respir J. 2020;56(5):2003616. doi: 10.1183/13993003.03616-2020
   PubMed Web of Science ®Google Scholar
• Ejalu DL, Irioko A, Kirabo R, et al. Cost-effectiveness of GeneXpert Omni compared with GeneXpert MTB/Rif for point-of-care diagnosis of tuberculosis in a low-resource, high-burden setting in Eastern Uganda: a cost-effectiveness analysis based on decision analytical modelling. BMJ Open. 2022;12(8):e059823. doi: 10.1136/bmjopen-2021-059823
   PubMed Web of Science ®Google Scholar
• Singh UB, Singh M, Sharma S, et al. Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF. Sci Rep. 2023;13(1): 6976.
   PubMed Web of Science ®Google Scholar
• Nandlal L, Perumal R, Naidoo K. Rapid molecular assays for the diagnosis of drug-resistant tuberculosis. Infect Drug Resist. 2022;15:4971–4984.
   PubMed Web of Science ®Google Scholar
• Jose R, Gopal K, Samuel Johnson A, et al. Evaluation of Truenat Mtb/Rif test in comparison with microscopy and culture for diagnosis of extrapulmonary tuberculosis in a tertiary care centre. J Clin Diagn Res. 2021;15(1). doi: 10.7860/JCDR/2021/46815.14432
   Web of Science ®Google Scholar
• Mangayarkarasi V, Sneka P, Sujith R. Jayaprakash Ergonomic diagnostic tool based on chip mini RT-PCR for diagnosis of pulmonary and extra pulmonary tuberculosis. J Pure Appl Microbiol. 2019;13:1185–1190. doi: 10.22207/JPAM.13.2.58
   Web of Science ®Google Scholar
• Sharma K, Sharma M, Sharma V, et al. Evaluating diagnostic performance of Truenat MTB Plus for gastrointestinal tuberculosis. J Gastroenterol Hepatol. 2022;37(8):1571–1578. doi: 10.1111/jgh.15878
   PubMed Web of Science ®Google Scholar
• Muthreja D, Swarnakar R, Sontakke A. Diagnostic utility of primary line probe assay in extrapulmonary tuberculosis. Eur Respir J. 2020;56:458.
   Web of Science ®Google Scholar
• World Health Organization. Geneva. WHO treatment guidelines for drug-resistant tuberculosis. 2016. https://www.who.int/publications/i/item/9789241549639.
   Google Scholar
• World Health Organization. Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians: 2022. https://www.who.int/publications/i/item/9789240046665.
   Google Scholar
• Diriba G, Kebede A, Tola HH, et al. Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia. SAGE Open Med. 2022;10:20503121221098241. doi: 10.1177/20503121221098241
   Web of Science ®Google Scholar
• Osei Sekyere J, Maphalala N, Malinga LA, et al. A comparative evaluation of the new genexpert MTB/RIF ultra and other rapid diagnostic assays for detecting tuberculosis in pulmonary and extra pulmonary specimens. Sci Rep. 2019;9(1):16587. doi: 10.1038/s41598-019-53086-5
   PubMedGoogle Scholar
• Mor P, Dahiya B, Sharma S, et al. Diagnosis of peritoneal tuberculosis by real-time immuno-PCR assay based on detection of a cocktail of Mycobacterium tuberculosis CFP-10 and HspX proteins. Expert Rev Gastroenterol Hepatol. 2022;16(6):577–586. doi: 10.1080/17474124.2022.2088509
   PubMed Web of Science ®Google Scholar
• Bloemberg GV, Voit A, Ritter C, et al. Evaluation of Cobas TaqMan MTB for direct detection of the Mycobacterium tuberculosis complex in comparison with Cobas Amplicor MTB. J Clin Microbiol. 2013;51(7):2112–2117. doi: 10.1128/JCM.00142-13
   PubMed Web of Science ®Google Scholar
• Borrás R, Martínez V, Vinuesa V, et al. Field performance of the Abbott RealTime MTB assay for the diagnosis of extrapulmonary tuberculosis in a low-prevalence setting. Enferm Infecc Microbiol Clin (Engl Ed). 2020;38(5):206–211. doi: 10.1016/j.eimc.2019.08.007
   PubMedGoogle Scholar
• Dong B, He Z, Li Y, et al. Improved conventional and new approaches in the diagnosis of tuberculosis. Front Microbiol. 2022;13:924410. doi: 10.3389/fmicb.2022.924410
   PubMed Web of Science ®Google Scholar
• Dippenaar A, Goossens SN, Grobbelaar M, et al. Nanopore sequencing for Mycobacterium tuberculosis: a critical review of the literature, new developments, and future opportunities. J Clin Microbiol. 2022;60(1):e0064621. doi: 10.1128/JCM.00646-21
   PubMed Web of Science ®Google Scholar
• Nurwidya F, Handayani D, Burhan E, et al. Molecular diagnosis of tuberculosis. Chonnam Med J. 2018;54(1):1–9. doi: 10.4068/cmj.2018.54.1.1
   PubMedGoogle Scholar
• Fischbach J, Xander NC, Frohme M, et al. Shining a light on LAMP assays’ a comparison of LAMP visualization methods including the novel use of berberine. Biotechniques. 2015;58(4):189–194. doi: 10.2144/000114275
   PubMed Web of Science ®Google Scholar
• Singh P, Kanade S, Nataraj G. Performance of loop-mediated isothermal amplification assay for diagnosis of extrapulmonary tuberculosis and antituberculosis treatment initiation. Int J Mycobacteriol. 2021;10(4):373–378. doi: 10.4103/ijmy.ijmy_218_21
   PubMed Web of Science ®Google Scholar
• Sharma K, Sharma M, Modi M, et al. Comparative analysis of truenat™ MTB plus and xpert® ultra in diagnosing tuberculous meningitis. Int J Tuberc Lung Dis. 2021;25(8):626–631. doi: 10.5588/ijtld.21.0156
   PubMed Web of Science ®Google Scholar
• Sharma K, Sharma M, Ayyadurai N, et al. Evaluating Truenat assay for the diagnosis of ocular tuberculosis and detection of drug resistance. Ocul Immunol Inflamm. 2023;2023:1–7. doi: 10.1080/09273948.2023.2170888
   Google Scholar
• Dahiya B, Prasad T, Singh V, et al. Diagnosis of tuberculosis by nanoparticle-based immuno-PCR assay based on mycobacterial MPT64 and CFP-10 detection. Nanomedicine (Lond). 2020;15(26):2609–2624. doi: 10.2217/nnm-2020-0258
   PubMed Web of Science ®Google Scholar
• Mehta PK, Dahiya B, Sharma S, et al. Immuno-PCR, a new technique for the serodiagnosis of tuberculosis. J Microbiol Methods. 2017;139:218–229. doi: 10.1016/j.mimet.2017.05.009
   PubMed Web of Science ®Google Scholar
• Sharma S, Sheoran A, Gupta KB, et al. Quantitative detection of a cocktail of mycobacterial MPT64 and PstS1 in tuberculosis patients by real-time immuno-PCR. Future Microbiol. 2019;14:223–233. doi: 10.2217/fmb-2018-0284
   PubMed Web of Science ®Google Scholar
• Dahiya B, Sharma S, Khan A, et al. Detection of mycobacterial CFP-10 (Rv3874) protein in tuberculosis patients by gold nanoparticle-based real-time immuno-PCR. Future Microbiol. 2020;15:601–612. doi: 10.2217/fmb-2019-0347
   PubMed Web of Science ®Google Scholar
• Dowling WB, Whitelaw A, Nel PTT. Tracing TB: are there predictors for active TB disease in patients with Xpert Ultra trace results? Int J Infect Dis. 2022;114:115–123. doi: 10.1016/j.ijid.2021.10.056
   PubMed Web of Science ®Google Scholar
• Ninan MM, Rupali P, Varghese GM, et al. Xpert Ultra in diagnosing extrapulmonary TB: accuracy and trace calls. Int J Tuberc Lung Dis. 2022;26(5):441–445. doi: 10.5588/ijtld.21.0480
   PubMed Web of Science ®Google Scholar